COPD2 min read
MucoLife Therapeutics secures €91K from Vinnova to scale manufacturing of COPD treatment
MucoLife Therapeutics has received €91,000 (SEK 1 million) from Vinnova, Sweden’s innovation agency, through the call “Support to small and medium-sized companies for the use of life science infrastru...
By Cate LawrenceTech.eu

Read the full story
Originally published by Tech.eu on Nov 6, 2026.
Comments
Sign in to join the discussion.